2020 annual financial data
Outlook Therapeutics 2020 Revenue growth
Direct answer
Revenue growth was -28.14%.
Operating income was -36,841,000 USD and net income was -35,239,000 USD.
Operating cash flow was Not available.
Get free Outlook Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 5,853,537 USD
- Operating income
- -36,841,000 USD
- Net income
- -35,239,000 USD
- Operating cash flow
- Not available